Hematopoietic stem cell transplantation in autoimmune diseases: Algorithm for cardiovascular assessment

Herz

Volumn 32, Issue 1, 2007, Pages 43-50

  Miniati, Irene ^a   Conforti, Maria Letizia ^a   Bernardo, Pasquale ^a   Tyndall, Alan ^b   Gensini, Gian Franco ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cardiac assessment; Cardiotoxicity; Immunosuppressive drugs; Stem cell transplantation; Systemic sclerosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE PHOSPHATE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; TROPONIN I;

AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; DERMATOMYOSITIS; DISEASE COURSE; DOPPLER ECHOGRAPHY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDITIS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART EDEMA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MOVEMENT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART SCINTISCANNING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MULTIPLE ORGAN FAILURE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; PERICARDITIS; PHYSICAL EXAMINATION; POLYMYOSITIS; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ALGORITHMS; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHYSICAL EXAMINATION; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 33847400583     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-2957-4     Document Type: Review

References (24)

1. Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology 2006;45:Suppl 4:iv4-7.
2. Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
3. Satoh M, Tokuhira M, Hama N, et al. Massive pericardial effusion in scleroderma: a review of five cases. Br J Rheumatol 1995;34:564-7.
4. Kamath S, Roobottom CA. Hyperdense pericardial effusion in dermatomyositis and contrast induced nephropathy. Emerg Radiol 2005;11:177-9.
5. Maksimovic R, Seferovic PM, Ristic AD, et al. Cardiac imaging in rheumatic diseases. Rheumatology 2006;45:Suppl 4:iv26-31.
6. Arslan S, Bozkurt E, Sari RA, et al. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol 2006;25:294-9.
7. Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin 1998;16:531-50.
8. Fluture A, Chaudhari S, Frishman WH. Valvular heart disease and systemic lupus erythematosus: therapeutic implications. Heart Dis 2003;5:349-53.
9. Riboldi P, Gerosa M, Luzzana C, et al. Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 2002;23:247-61.
10. Roman MJ, Salmon JE, Sobel R, et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus eryhematosus and antiphospholipid antidobies syndrome. Am J Cardiol 2001;87:663-6.
11. Kahan A., Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006;45:14-7.
12. Bulkey BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976;53:483-90.
13. James TN. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974;50:844-56.
14. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
15. Maisch B, Pankuweit S, Karatolios K, et al. Invasive techniques - from diagnosis to treatment. Rheumatology 2006;45:Suppl 4:iv32-8.
16. Ferri C, Emdin M, Nielsen H, et al. Assessment of heart involvement. Clin Exp Rheumatol 2003;21:Suppl 29:S24-8.
17. Janosik DL, Osborn TG, Moore TL, et al. Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989;19:191-200.
18. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.
19. Lundbeg IE. The heart in dermatomyositis and polymyositis. Rheumatology 2006;45:Suppl 4:iv18-21.
20. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-78.
21. Pramod S, Masood A. A case of atrial fibrillation from cyclosporine toxicity. Indian Pacing Electrophysiol J 2004;4:40-2.
22. Santos GW, Sensenbrenner LL, Burke PJ, et al. Marrow transplanation in man following cyclophosphamide. Transplant Proc 1971;3:400-4.
23. Saccardi R, Tyndall A, Coghlan G, et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004;34:877-81.
24. Van Besien K, Devine S, Wickrema A, et al. Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone Marrow Transplant 2003;32:471-6.